Le Lézard
Classified in: Health
Subject: SVY

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017



LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary



Download the full report: https://www.reportbuyer.com/product/4465336


GlobalData's Medical Devices sector report, "Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Lung Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
- Extensive coverage of the Lung Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Lung Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Lung Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/4465336

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com  

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 01:00
Regeneron Pharmaceuticals, Inc. and ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced a clinical collaboration to advance ISA101, an immunotherapy targeting human papillomavirus type 16 (HPV16)-induced cancer, in...

at 00:00
MEDIA ADVISORY:   Ensuring that product data initiatives work harder for the business is a challenge for most organizations in Life Sciences. In its upcoming webinar - Master data management 2.0: Next-generation content management meets Integral...

17 déc 2017
Media are invited to join Stéphane Bertrand, CEO of Les Serres Stéphane Bertrand Inc. and Adam Greenblatt, Quebec Brand Manager for Canopy Growth Corporation as they make an important announcement related to cannabis production Date: December 18,...

17 déc 2017
VivaLNK announces Vital Scout, a wellness assessment patch for medical grade accuracy not seen before with wrist worn devices. The Vital Scout uses electrocardiography (ECG) and 3D accelerometer sensors to monitor Heart Rate (HR), Respiration Rate...

16 déc 2017
In the evening of December 16th, the 15th Guignolée du Dr Julien, the Fondation's annual fundraising drive in support of its three centres of expertise had raised $1,143,335. This first count is a testament to the...

16 déc 2017
We at Baycrest are completely shocked and profoundly saddened by the deaths of Barry and Honey Sherman. They were visionary leaders, and their commitment and philanthropy improved the lives of countless Canadians. Barry and Honey generously helped to...




News published on 6 october 2017 at 10:38 and distributed by: